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A number of mechanisms have been proposed to explain the
pathogenesis of atrial ﬁbrillation (AF), and some are intri-
cately linked to the autonomic nervous system (ANS) (1). A
potential neural inﬂuence in AF was suggested by Coumel
et al. (2) in 1978 and has since been extensively investigated.
Experimentally, stimulation of autonomic nerves during the
atrial refractory period has been shown to produce rapid
ectopic beats from the pulmonary veins (PVs) and superior
vena cava, which in turn can initiate AF (3,4). It is now well
recognized that the ANS has an important contribution to
the pathogenesis of AF (5,6). However, AF remains poorly
understood, and the speciﬁc mechanisms underlying the
relationship between the ANS and AF have yet to be fully
elucidated. Despite this limited knowledge base, both car-
diac and extra-cardiac autonomic structures (such as the
renal arteries) have been targets of AF therapy (7).See page 1892Anatomically, the ANS has direct projections to the
heart and also indirect projections via the intrinsic cardiac
nervous system (ICN), distributed into ganglionated plexi
(GPs). GPs are not simply “relay stations” for ANS pro-
jections to the heart; they contain sympathetic efferent,
parasympathetic efferent, sensory afferent, and local circuit
neurons (8,9). Extensive processing of these inputs occurs
at the level of the ICN.
There is increasing evidence that the ICN plays an active
role in the regulation of cardiac function. For example, the
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Angeles, California.right PV complex, mediates vagal control of the sinoatrial
(SA) node. Disruption of the RAGP eliminates para-
sympathetic projections to the SA node but leaves intact
parasympathetic-mediated suppression of sympathetic pro-
jections to the SA node (10). GPs exert inﬂuence locally but
can also inﬂuence distant regions. Stimulation of neurons in
the RAGP with nicotine, for example, causes changes in
unipolar wave forms not only in the atria but also surprisingly
in the ventricles. Thus, spatially divergent and overlapping
cardiac regions are under the inﬂuence of neurons
throughout the ICN (11). This also implies a certain degree
of redundancy in the network.
Imbalances in the ICN are thought to be involved in
the pathogenesis of AF. Although still controversial,
numerous strategies have been used to ablate GPs as
adjunctive (12) or stand-alone (13) therapy in the treat-
ment of AF. These approaches have relied on functionally
identifying GP regions to target energy delivery, on the
basis of autonomic responses to electrical stimulation.
Other methods are anatomic, such as targeting the vein of
Marshall (VOM) (14), either surgically or by catheter-
based approaches (15–17).The present study. In this issue of the Journal, Báez-Escudero
et al. (18) describe the use of the VOM as a vascular route
for the ablation of ICN neurons. The VOM is continuous
with the ligament of Marshall (LOM), a vestigial remnant
of the embryologic left cardinal vein (14). The LOM is an
epicardial ﬁbrous and neuromuscular bundle that runs from
the roof of the left atrium, past the left superior PV, and
inserts into the distal coronary sinus (CS) (19). Several
studies have now shown that the LOM can trigger and
help maintain AF. Doshi et al. (20) demonstrated that
isoproterenol infusion was able to induce automatic activity
in the LOM that led to AF. Furthermore, histologic
evaluation of the LOM revealed muscle tracts surroun-
ded by nerve bundles positive for tyrosine-hydroxylase (a
sympathetic ANS marker), providing more evidence in
support of the relationship between the ANS and ICN in
the initiation of AF (20). Because the VOM has a direct
connection with the CS, the VOM can be used to access
the ICN neurons within the LOM. Antiarrhythmic drugs
have been injected via the CS to terminate AF; presumably
such drugs could interact with these neural structures (21).
In this study, the VOM was cannulated in patients who
required either de novo or repeat AF ablation. Para-
sympathetic responses (asystole or RR prolongation) were
elicited with high-frequency stimulation, among patients
who could have the VOM cannulated. Chemical ablation of
the VOM with retrograde ethanol infusion eliminated
parasympathetic responses and rendered AF noninducible
(when tested via high frequency stimulation within the
VOM) in a majority of the patients.
These ﬁndings are important on multiple fronts.
Although AF ablation is improving, currently the success
rate is suboptimal, with many patients requiring repeat
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1903procedures. Thus, new approaches to treat AF are critical.
This study was possible due to our improved understanding
of the link between the ANS and AF; targeted GP ablation
might become another tool in the therapeutic armamen-
tarium against AF.
Although the ﬁndings are intriguing, there are some
limitations. A study by Leiria et al. (22) demonstrated that
cryoablation of cardiac mediastinal nerves with input into
the ICN resulted in a short-term reduction in AF.
However, this stunning effect was time-dependent, and
AF induction recovered to nearly baseline levels several
months later (22). This recovery of inducibility with time
illustrates the plasticity of the ICN in response to local
injury. There is also evidence to suggest disruption of the
ICN can have pro-arrhythmic effects on atrial tissue (23).
Another limitation is that it is not possible to assess the
contribution of atrial and PV myocardial junction ablation
to the reduction of AF induction (24). There is also the
clinical reality that the VOM is absent or too small to
be cannulated in some patients, potentially increasing
procedure time.
Finally, the effects of GP ablation on ventricular elec-
trophysiology and arrhythmogenesis remain to be carefully
evaluated. A recent study by He et al. (25) demonstrated
that GP ablation signiﬁcantly increased the risk of ventric-
ular arrhythmias in the setting of acute myocardial ischemia
(25). Thus, targeting of the ICN has the potential to create
further instability in the neural network and exacerbate the
risk for arrhythmias, and these patients should be carefully
followed (26).
Implications. The ﬁndings of this study underscore the
importance of improving our understanding of the role of the
ICN in regulating cardiac function and in arrhythmogenesis.
Careful evaluation of the short- and long-term effects of
disrupting ICN elements on both atrial and ventricular
function and electrophysiology are crucial before targeted GP
ablation becomes part of clinical practice.
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